Literature DB >> 19932818

Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase.

M Dumarey1, R Sneyers, W Janssens, I Somers, Y Vander Heyden.   

Abstract

The use of dissimilar chromatographic systems in drug impurity profiling can be very advantageous. Screening a new-drug impurity mixture on those systems not only enhances the chance that all impurities are revealed, but also allows choosing a suited system for further method development. In this paper several strategies were evaluated to predict the optimal pH (of the buffer used in the mobile phase) from the screening results. Four or five dissimilar stationary phases were screened at four pH values (between 2.5 and 9.4), in order to obtain maximal information about the composition of the sample and to select one column for the subsequent optimization. Different linear models (straight lines, 2nd and 3rd degree polynomials) based on these experiments were tested for their ability to predict the retention times (t(R)) of the impurities at intermediate pH values. The predicted t(R) values were then used to calculate minimal resolutions and eventually to select an optimal pH at which the highest minimal resolution is predicted. None of the applied models is accurate enough to predict correctly which peaks are worst separated at the indicated optimal pH. However, the best strategy (applying a second degree polynomial describing the t(R) measured at 3 consecutive screening pH values) did succeed in indicating an optimal pH at which a good separation of the impurities is obtained. Unfortunately, the resulting separation quality is not or only slightly better than the best separation obtained during screening. Therefore, it can be concluded that the most (time-) efficient approach to develop an impurity profile of a new drug is to screen it on four or five dissimilar columns at four different pH values and to retain the best screening conditions (without making predictions for intermediate conditions) for further optimization of the organic modifier composition of the mobile phase, and occasionally the temperature and the gradient. This is at least the case when the profiles have a complexity similar to those studied.

Mesh:

Substances:

Year:  2009        PMID: 19932818     DOI: 10.1016/j.aca.2009.10.013

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  2 in total

1.  A systematic assessment of genotoxicity on pivaloylacylation-7ADCA-a wide existing antibiotic impurity.

Authors:  Qingying Luo; Yang Li; Zunzhen Zhang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

2.  Identification of the Impurities in Bopu Powder® and Sangrovit® by LC-MS Combined with a Screening Method.

Authors:  Zhuang Dong; Mengting Liu; Xiaohong Zhong; Xiaoyong Ou; Xuan Yun; Mingcan Wang; Shurui Ren; Zhixing Qing; Jianguo Zeng
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.